NCT00273559View on ClinicalTrials.gov

A Study Comparing Outcomes of Kidney Transplants in Patients on Steroids Versus Those Who Discontinue Steroids

UnknownOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2006

Study Completion Date

December 31, 2008

Conditions
Kidney Diseases
Interventions
DRUG

prednisone

group 2 will remain on 5 mg of prednisone for at least 90 days post transplant.

Trial Locations (1)

32804

Florida Hospital Transplant Center, Orlando

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Genzyme, a Sanofi Company

INDUSTRY

collaborator

Novartis

INDUSTRY

lead

Florida Hospital Transplant Center

OTHER